VULLO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.895
EU - Europa 7.803
AS - Asia 1.652
AF - Africa 103
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 31.469
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.858
RU - Federazione Russa 2.409
PL - Polonia 2.287
IE - Irlanda 986
IT - Italia 777
SE - Svezia 608
SG - Singapore 529
HK - Hong Kong 412
CN - Cina 302
FI - Finlandia 280
IN - India 193
GB - Regno Unito 148
DE - Germania 133
TR - Turchia 101
CI - Costa d'Avorio 99
VN - Vietnam 82
ES - Italia 72
UA - Ucraina 60
CA - Canada 37
JO - Giordania 19
BE - Belgio 15
BR - Brasile 8
NL - Olanda 8
JP - Giappone 7
CH - Svizzera 6
LT - Lituania 4
EU - Europa 3
IR - Iran 3
NO - Norvegia 3
AT - Austria 2
CO - Colombia 2
FR - Francia 2
MU - Mauritius 2
SA - Arabia Saudita 2
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
EE - Estonia 1
KR - Corea 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RO - Romania 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 31.469
Salva come PNG Salva come JPEG
Città #
Fairfield 4.261
Warsaw 2.287
Santa Clara 2.160
Woodbridge 2.124
Ashburn 1.882
Seattle 1.827
Cambridge 1.658
Houston 1.556
Wilmington 1.279
Dublin 981
Chandler 698
Ann Arbor 563
Lawrence 508
Altamura 504
Princeton 423
Singapore 406
Boston 172
Medford 172
Jacksonville 171
Boardman 158
Hong Kong 156
San Diego 150
Mumbai 139
Florence 114
Beijing 104
Abidjan 99
Moscow 86
Dong Ket 78
Falls Church 72
Barcelona 71
Norwalk 56
Izmir 52
Hillsboro 33
Shanghai 33
Toronto 32
Andover 30
Kent 27
London 24
Düsseldorf 21
New York 20
Yubileyny 19
Dearborn 17
Guangzhou 17
Phoenix 16
Rome 16
Brussels 15
Helsinki 13
Redmond 13
Tappahannock 13
Los Angeles 12
Wuhan 12
Chiswick 10
Gavirate 9
Buffalo 8
Redwood City 8
West Jordan 8
Prescot 7
Bern 6
Hounslow 6
Kilburn 6
Milan 6
Esslingen am Neckar 5
Grevenbroich 5
Laurel 5
Washington 5
Detroit 4
Fuzhou 4
Islington 4
Leawood 4
Messina 4
Rui'an 4
Salerno 4
Serra 4
Araraquara 3
Cagliari 3
Jiaxing 3
Montréal 3
New Bedfont 3
Palermo 3
Portici 3
Scandicci 3
Shenzhen 3
Wandsworth 3
Zibo 3
Acton 2
Bogotá 2
Böblingen 2
Castelnuovo Berardenga 2
Catania 2
Fontebuona 2
Hangzhou 2
L'aquila 2
Lanciano 2
Misano Adriatico 2
Montelupo Fiorentino 2
Naaldwijk 2
Nanjing 2
Naples 2
Nürnberg 2
Palombara Sabina 2
Totale 25.541
Salva come PNG Salva come JPEG
Nome #
Carbonic anhydrases activation with 3-amino-1H-1,2,4-triazole-1-carboxamides: Discovery of subnanomolar isoform II activators 247
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis 243
Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity. 236
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis 236
Sulfonamide inhibition profile of the γ-carbonic anhydrase identified in the genome of the pathogenic bacterium Burkholderia pseudomallei the etiological agent responsible of melioidosis 234
Ferrier sulfamidoglycosylation of glycals catalyzed by nitrosonium tetrafluoroborate: Towards new carbonic anhydrase glycoinhibitors 230
Natural product coumarins that inhibit human carbonic anhydrases. 229
Carbonic Anhydrase Activators: Gold Nanoparticles Coated with Derivatized Histamine, Histidine, and Carnosine Show Enhanced Activatory Effects on Several Mammalian Isoforms. 223
Natural product polyamines that inhibit human carbonic anhydrases 217
Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect 216
Ascaris lumbricoides β carbonic anhydrase: A potential target enzyme for treatment of ascariasis 214
Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. 208
Mapping Selective Inhibition of the Cancer-Related Carbonic Anhydrase IX Using Structure-Activity Relationships of Glucosyl-Based Sulfamates 208
Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae 207
Anion inhibition studies of a beta carbonic anhydrase from the malaria mosquito Anopheles gambiae 203
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? 186
7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits α-carbonic anhydrases without hydrolysis of the lactam ring. 175
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 172
Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII 172
Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase 170
S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. 156
Analysis of a shortened form of human carbonic anhydrase VII expressed in vitro compared to the full-length enzyme. 151
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense. 146
In vitro inhibition of Mycobacterium tuberculosis β-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos 141
Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. 139
Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. 139
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis 137
Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. 136
Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions. 135
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. 134
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. 133
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. 133
Design and validation of FRESH, a drug discovery paradigm resting on robust chemical synthesis 133
Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei 133
Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. 132
Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates. 131
Potent and Selective Carboxylic Acid Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII 131
Plasmonic Particles that Hit Hypoxic Cells 131
Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety. 129
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis. 129
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. 129
Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. 129
Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. 128
Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. 127
Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails. 127
Pyridinium derivatives of histamine are potent activators of cytosolic carbonic anhydrase isoforms I, II and VII. 127
Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. 126
A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents 126
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases. 125
Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. 124
Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines. 124
Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. 124
4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII 124
Biochemical characterization of the δ-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA 124
Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action 124
Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. 123
Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. 123
Carbonic anhydrase inhibitors: glycosylsulfanilamides act as subnanomolar inhibitors of the human secreted isoform VI. 123
Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors. 123
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. 123
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 123
Carbonic anhydrase activators: the first activation study of the human secretory isoform VI with amino acids and amines. 122
Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides. 122
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. 122
Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters. 122
Metallocene-based inhibitors of cancer-associated carbonic anhydrase enzymes IX and XII. 121
A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome 121
Biochemical characterization of the native α-carbonic anhydrase purified from the mantle of the Mediterranean mussel, Mytilus galloprovincialis 121
Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum 121
Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. 120
Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV. 120
Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives. 120
Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties. 120
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition. 120
Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV. 120
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates. 120
Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions. 119
Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. 119
Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with benzo[b]thiophene 1,1-dioxide sulfonamides. 119
Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors. 119
Hyperchlorhidrosis caused by homozygous mutation in CA12, encoding carbonic anhydrase XII. 118
Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties. 118
Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). 118
Reconstitution of carbonic anhydrase activity of the cell-surface-binding protein of vaccinia virus. 117
Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics 117
Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates 117
Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma. 117
Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties. 117
Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors. 117
Carbonic anhydrase I and II activation with mono- and dihalogenated histamine derivatives. 116
Carbonic anhydrase inhibitors. inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with anions. 116
Structural and inhibition insights into carbonic anhydrase CDCA1 from the marine diatom Thalassiosira weissflogii. 116
Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II. 115
Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans. 115
Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold. 115
The first activation study of a bacterial carbonic anhydrase (CA). The thermostable α-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines. 115
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 115
Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis 114
5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations 114
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors 113
Totale 14.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.750
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.423 0 0 0 0 1.083 1.083 1.097 1.073 1.006 474 407 200
2020/20213.542 355 448 219 289 269 323 125 275 354 387 252 246
2021/20222.025 90 215 276 52 50 98 110 171 70 95 208 590
2022/20234.119 610 1.103 82 213 285 745 449 146 283 49 101 53
2023/20241.198 79 165 334 57 72 145 38 181 24 40 35 28
2024/20256.080 394 1.108 704 1.288 2.586 0 0 0 0 0 0 0
Totale 31.707